A new option for remission induction in acute myeloid leukaemia
Author:
Publisher
Elsevier BV
Subject
Oncology
Reference10 articles.
1. Acute myeloid leukemia;Döhner;N Engl J Med,2015
2. International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts;Dombret;Blood,2015
3. TP53 and decitabine in acute myeloid leukemia and myelodysplastic syndromes;Welch;N Engl J Med,2016
4. DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients >60 years with acute myeloid leukemia who are ineligible for induction chemotherapy
5. Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the Study Alliance Leukemia;Müller-Tidow;Leukemia,2016
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. BH3 Mimetics in AML Therapy: Death and Beyond?;Trends in Pharmacological Sciences;2020-11
2. Inhibition of PLK1 by capped‐dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis;European Journal of Haematology;2019-12-08
3. Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose;Experimental Hematology & Oncology;2019-04-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3